Home/Filings/4/0000950170-23-068903
4//SEC Filing

McGrath Yvonne 4

Accession 0000950170-23-068903

CIK 0001808865other

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 8:22 PM ET

Size

4.8 KB

Accession

0000950170-23-068903

Insider Transaction Report

Form 4
Period: 2023-12-05
McGrath Yvonne
Chief Scientific Officer
Transactions
  • Award

    Common Stock

    2023-12-05+31,00031,000 total
Footnotes (1)
  • [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. All of the shares of common stock underlying such RSUs will vest on December 5, 2025, subject to the Reporting Person's continued service to the Issuer.

Documents

1 file

Issuer

iTeos Therapeutics, Inc.

CIK 0001808865

Entity typeother

Related Parties

1
  • filerCIK 0001816213

Filing Metadata

Form type
4
Filed
Dec 6, 7:00 PM ET
Accepted
Dec 7, 8:22 PM ET
Size
4.8 KB